
Keywords: داکلیزومب; AE; adverse event; ALT; alanine aminotransferase; AST; aspartate aminotransferase; DRESS; drug reaction with eosinophilia and systematic symptoms; DSMB; data safety monitoring board; GGT; gamma-glutamyl transferase; GI; gastrointestinal; IL-2; interleukin